Home » Posts tagged with "Novartis"
FDA approves 1st living drug to treat cancer in the US
The Food and Drug Administration has approved the first-ever gene therapy to treat cancer in the US. The treatment offers a totally new approach to fighting the disease and could lead to novel treatments of other serious and life-threatening maladies.
On Wednesday, the FDA approved a new leukemia treatment from the Swiss pharmaceutical company Novartis, which the agency said is “the first gene therapy...
All UK Babies to Receive Meningitis Vaccine, Despite Package Insert Warnings
“Safety and effectiveness of Bexsero have not been established in children younger than 10 years of age,” vaccine insert states…
The UK government has announced it will begin vaccinating babies two months of age and older against meningitis B, an audacious campaign undertaken despite published warnings from vaccine manufacturers.
“I am very proud that we will be the first country in the...
Americans consume 50% of total World Pharmaceutical Drugs
While Americans comprise only 5 percent of the world population, we consume an incredible 50 percent of Big Pharma’s drugs, as explained in Jeff Hays’ documentary film, Doctored. Make no mistake. These drugs are meant to keep us imprisoned in poor health, not heal us. It’s time to kick the drug habit America. Tell the drug pushers – Merck, Pfizer, Novartis, Roche, GlaxoSmith Kline, Abbott,...
US probes Swiss medicine giant for trade with Iran
An Iranian cancer patient who like millions of other patients with intractable diseases, is victim of anti-Iran sanctions imposed by US and EU to block financial transactions for the purchase of medications.
Despite its claims of easing the restrictions on the sales of medicine to Iran, Washington has launched an investigation into the transactions of Switzerland’s biggest pharmaceutical company,...
Germany and Spain seek to cut swine flu vaccine orders as millions refuse to take shot
Vaccines
Germany and Spain want to reduce deliveries of swine flu vaccine and potentially return excess supplies to manufacturers, due to low uptake of the shots, in a move that could hit drugmakers’ profits.
Germany’s health ministry said on Thursday some German states had been in talks with Britain’s GlaxoSmithKline about reducing deliveries of H1N1 vaccine, but the talks had as...